Conditions & Recovery · STAT News · September 8, 2026

A breakthrough pancreatic cancer drug won approval. They still struggle to access it

When the FDA approved a new pancreatic cancer drug called Rasonque, researchers celebrated. But some patients hoping for quick access have been stymied.

Originally published by STAT News. We curate and add context; they did the reporting.

Read the full story at STAT News ↗

Related learning

Biotech Firm Claims Some Credit for Groundbreaking Virus Research Biotech Firm Claims Some Credit for Groundbreaking Virus Research James P. Allison, Ph.D., bangs gong after completing proton therapy treatment Combination therapy helps plasmacytoid bladder cancer survivor